The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: Heart failure - Primary Care

Thursday, 08 September 2016
The American Heart Association has published a scientific statement providing prescribers with a list of drugs that can cause or worsen heart failure. Heart failure patients are usually taking medications for multiple medical conditions with resulting risk for drug-drug or drug-condition interactions.
Category: Have You Heard
Thursday, 16 June 2016
A large amount of evidence points to the effectiveness of optimising primary care heart failure management in reducing referral to hospital and improving outcomes for patients. This article describes the changes made in a primary care practice that has resulted in measurable difference for the primary care team and their patients.
Category: Editorial
Monday, 21 November 2016
HF has a major impact on patients, their families, the NHS and social care services. It still has a poor prognosis, worse than many of the common cancers that also affect older people. It causes significant morbidity and imposes a major cost burden on the health service. This editorial provides an introduction to a special supplement on a first-in-class oral treatment for heart failure.
Category: Editorial
Monday, 21 November 2016
The UK faces an epidemic of heart failure (HF). NICE guidelines emphasise the importance of multidisciplinary assessment and care by HF specialists, evidence-based prescribing, and careful discharge planning after hospitalisation. This article highlights areas where improvements can be made in the management of HF including taking lessons from the latest National Heart Failure Audit.
Category: Editorial
Wednesday, 13 December 2017
Between 2002 and 2014, the number of new cases of heart failure in the UK increased by 12% – from 170,727 to 190,798 cases, according to the most comprehensive review of heart failure statistics in the UK. The number of new heart failure cases in 2014 was similar to the combined number of new cases of breast, prostate, lung and bowel cancer (189,136 cases in 2014).
Wednesday, 07 June 2017
Men and women suffering from heart failure have a higher risk of death than people with some common types of cancer, according to results from the primary care database study. Heart failure is also accompanied by much higher rates of co-morbidity.
Friday, 30 October 2015
Heart failure (HF) was singled out as an emerging epidemic in 1997. Since then, rates have continued to rise and it remains a major public health problem with a prevalence ofmore than 23 million worldwide. HF is associated with significant morbidity, mortality and healthcare costs, particularly in the over-65s. Changes in the case mix mean morepatients are presenting with preserved ejection fraction, for which management is aimed to stop progression, relieve symptoms, eliminate exacerbations and reduce the mortality. Despite reductions in HF-related mortality, hospitalisations remain frequent and readmissions continue to rise. It is these admissions to hospital that put a financialstrain on the local health economy, and cause stress and anxiety for the patient and supporting family.
Category: Editorial
Monday, 21 November 2016
A number of drug classes are used in the treatment of patients with heart failure. This illustrated Back to Basics poster describes the various drugs and their mechanisms of action to give health care professionals and their patients a greater understanding of heart failure management and where sacubitril/valsartan fits into the picture.
Category: Back to Basics
Tuesday, 10 April 2018
Heart failure (HF) is a devastating clinical syndrome characterised by a constellation of symptoms and signs in the presence of reduced cardiac function. Comorbidity is almost inherent as HF is often the culmination of chronic disease processes such as ischaemic heart disease, hypertension and valve disease and its treatment may precipitate comorbidities such as gout, erectile dysfunction (ED) and acute kidney injury (AKI).
Category: Editorial
Tuesday, 26 April 2016
The outlook is bleak for patients with untreated or suboptimally treated heart failure (HF). Conversely, optimising management (HF) improves patient survival and reduces hospital admissions. However, standards of care continue to vary, and many HF patients are still not receiving recommended therapy with disease-modifying drugs or specialist input to their care. Outcomes will only improve for all our HF patients if evidence-based clinical guidelines are implemented throughout the NHS.
Category: Editorial
Page 1 of 4

Article search and filter